Research Fellow

The petition was approved based on a Ph.D. in medicinal chemistry and a record of 20 peer-reviewed scientific articles and 3 patent applications. His work garnered 237 citations from researchers in at least 33 countries, demonstrating sustained international acclaim. Additionally, he satisfied the judging criterion by conducting at least 20 manuscript reviews for highly discerning journals.

The petition was approved based on 43 peer-reviewed articles, 2 book chapters, and 6 patents which garnered 362 citations from researchers in 35 countries. Additionally, the petitioner demonstrated extraordinary ability through a significant record of 70 peer review assignments for professional journals. These metrics satisfied the EB-1A criteria for scholarly articles, original contributions, and judging the work of others.

The case was approved based on the petitioner's 15 peer-reviewed scientific articles with a cumulative impact factor of 69.504 and 233 citations from peers in 37 countries. He demonstrated extraordinary ability through 92 peer review assignments and editorial positions at 5 prestigious journals. His research provided practical applications for treating complex diseases like diabetes and tuberculosis.

The petition was approved based on meeting at least three EB-1A criteria: authorship of scholarly articles, participation as a judge of others' work, and original scientific contributions of major significance. Specific metrics included 34 journal articles in high-impact venues like Cell Chemical Biology, 1,306 citations with an h-index of 17, and over 25 completed manuscript reviews. Evidence of the commercialization of key compounds further demonstrated the petitioner's extraordinary ability.